@Article{,
AUTHOR = {Judd W. Moul, Fred Saad},
TITLE = {Low-risk prostate cancer patient: active treatment},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {12},
YEAR = {2005},
NUMBER = {Suppl.3},
PAGES = {25--27},
URL = {http://www.techscience.com/CJU/v12nSuppl.3/63365},
ISSN = {1488-5581},
ABSTRACT = {We currently lack a prospective, randomized, multicenter
trial, to reassure low-risk prostate cancer patients,
especially younger ones, that watchful waiting is a
legitimate treatment. To better manage these patients,
we need to: first, confirm that the patient has low-risk
prostate cancer; second, adapt the treatment to the risk (i.e., if therapy is chosen over watchful waiting, it should
be monotherapy not multiple therapy); third, be aware of
age migration; fourth, know that radical prostatectomy
and radiation were shown to be very effective for these
patients at 10-year follow-up; and lastly, make an effort
to better define watchful waiting and embrace it more, to
avoid overtreatment.},
DOI = {}
}